Production of chimeric human papillomavirus

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C424S205100, C424S184100, C435S069100

Reexamination Certificate

active

06841157

ABSTRACT:
This invention relates to infectious chimeric papillomaviruses, and especially those where the early genes are from human papillomavirus (HPV) 18, and the late genes are from another HPV. Also presented are methods of culturing the virus in raft cell cultures, and to assays utilizing these chimeric viruses.

REFERENCES:
patent: 5376542 (1994-12-01), Schlegal et al.
patent: 5576206 (1996-11-01), Schlegel et al.
patent: 5618536 (1997-04-01), Lowy et al.
patent: 5855891 (1999-01-01), Lowy et al.
patent: 5955087 (1999-09-01), Whittle et al.
patent: 5994115 (1999-11-01), Meyers et al.
patent: 6004557 (1999-12-01), Edwards et al.
patent: 6352696 (2002-03-01), Hallek et al.
patent: WO 9619496 (1996-06-01), None
patent: WO 9802548 (1998-01-01), None
patent: WO 9904811 (1999-02-01), None
patent: WO 0208264 (2002-01-01), None
Meyers, et al. 1997, J. Virol. 71(10): 7381-86.
Meyers, et al. 1992, Science 257: 971-73.
Kreider et al. 1987, J. Virol 61:590.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Production of chimeric human papillomavirus does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Production of chimeric human papillomavirus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Production of chimeric human papillomavirus will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3416539

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.